GLOVER STEPHEN C. purchased 23.6% of their position (15.06K shares) of PDS BIOTECHNOLOGY CORP on the open market
Open‑market purchase worth $25.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/3/2025ACC: 0001140361-25-006783
+30.12K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
30.12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15.06K
Price / share
$1.66
Trade value
$25K
% of position
23.6%
2/28/2025
63.79K→78.85K
Total
Net shares
+15.06K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/28/2025 | P · Purchase | +15.06K | $1.66 | $25K | 23.6% | 63.79K | 78.85K |
| Total | +15.06K | $25K | ||||||
Derivative Transactions1
Common Warrant
Direct
Converts to
Common Stock
15.06K shares
Shares
+15.06K
Strike price
1.53
Held after
15.06K
Exercisable
—
2/28/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Warrant Direct | Common Stock15.06K shares | 2/28/2025 | P · Purchase | +15.06K | 1.53 | — | 15.06K |